Skip to content
Directory

Treatment, Medication & Supplement Directory

A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.

Directory explains “what it is.”Guides explain how owners can discuss, use, monitor, or prepare for a treatment option with veterinary guidance.
Filter

Filter

24 directory found

Species
See more See less
Product Family
See more See less
Regulatory Status
Search
24 entriesShowing 13–24
Veterinarian assessing comfort and mobility with a calm dog and caregiverNamed profile Buprenorphine in Veterinary Oncology: Opioid Formulations and Species BoundariesRepresentative category illustration – no product packaging is shown.
Pain Medication · Prescription Drug · Partial mu-opioid agonists · Dogs & Cats · After Surgery · Long-term Management · Palliative / Comfort Care

Buprenorphine in Veterinary Oncology: Opioid Formulations and Species Boundaries

buprenorphine is covered as prescription controlled opioid analgesic, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian reviewing hydration and digestive symptom monitoring with a dog caregiverNamed profile Acid-Suppression Medicines in Veterinary Oncology: Rational-Use ProfileRepresentative category illustration – no product packaging is shown.
Supportive-care medicine · Gastric acid-suppression medicines · Dogs & Cats · After Surgery · During Chemotherapy · Palliative / Comfort Care · Published Study

Acid-Suppression Medicines in Veterinary Oncology: Rational-Use Profile

proton-pump inhibitors and histamine-2 receptor antagonists is covered as gastrointestinal supportive-medicine class, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinary nutrition consultation with a dog and caregiverNamed profile Cobalamin (Vitamin B12) in Canine and Feline Oncology SupportRepresentative category illustration – no product packaging is shown.
Nutrition Support · Supportive-care medicine · Cobalamin replacement · Dogs & Cats · During Chemotherapy · Long-term Management · Published Study

Cobalamin (Vitamin B12) in Canine and Feline Oncology Support

cobalamin (vitamin B12) is covered as nutrient replacement for documented or strongly suspected deficiency; not a universal cancer supplement, with species, evidence, regulatory, safety, interaction and monitoring boundaries…

Read more
Veterinarian reviewing organ protection, hydration and laboratory monitoring with a dogNamed profile Mesna in Veterinary Oncology: Uroprotection With Ifosfamide and CyclophosphamideRepresentative category illustration – no product packaging is shown.
Prescription Drug · Supportive-care medicine · Thiol uroprotectants · Dogs · During Chemotherapy · Published Study · Veterinary Clinical Use

Mesna in Veterinary Oncology: Uroprotection With Ifosfamide and Cyclophosphamide

mesna (sodium 2-mercaptoethane sulfonate) is covered as protocol-linked uroprotective medicine; not antitumour therapy, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian reviewing organ protection, hydration and laboratory monitoring with a dogNamed profile Dexrazoxane in Veterinary Oncology: Anthracycline Rescue and CardioprotectionRepresentative category illustration – no product packaging is shown.
Prescription Drug · Supportive-care medicine · Anthracycline protective agents · Dogs & Cats · During Chemotherapy · Limited / Emerging Evidence · Veterinary Clinical Use

Dexrazoxane in Veterinary Oncology: Anthracycline Rescue and Cardioprotection

dexrazoxane is covered as emergency extravasation antidote and selected anthracycline cardioprotectant, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian reviewing organ protection, hydration and laboratory monitoring with a dogNamed profile Furosemide as a Cyclophosphamide Uroprotection Adjunct in DogsRepresentative category illustration – no product packaging is shown.
Prescription Drug · Supportive-care medicine · Cyclophosphamide bladder-protection strategies · Dogs · During Chemotherapy · Published Study · Veterinary Clinical Use

Furosemide as a Cyclophosphamide Uroprotection Adjunct in Dogs

furosemide used as a protocol adjunct is covered as loop diuretic used within selected canine cyclophosphamide protocols; not antitumour therapy, with species, evidence, regulatory, safety, interaction and monitoring…

Read more
Caregiver and veterinary professional reviewing symptom observations for a dogNamed profile H1 and H2 Blockade Around Mast-Cell Degranulation RiskRepresentative category illustration – no product packaging is shown.
Prescription Drug · Supportive-care medicine · Mast-cell mediator blockade · Dogs · During Targeted Therapy · Veterinary Clinical Use · Label-linked companion-medication context

H1 and H2 Blockade Around Mast-Cell Degranulation Risk

H1-receptor and H2-receptor blocking companion medicines is covered as protocol-linked supportive medicines; not direct antitumour treatment, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led…

Read more
Veterinary team and caregiver reviewing an oncology treatment calendar for a dogNamed profile COP / CVP Lymphoma Chemotherapy: Veterinary Protocol ProfileRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · COP / CVP lymphoma protocols · Dogs & Cats · During Chemotherapy · New Diagnosis · Published Study

COP / CVP Lymphoma Chemotherapy: Veterinary Protocol Profile

cyclophosphamide, vincristine (Oncovin) and prednisone or prednisolone is covered as multi-agent lymphoma chemotherapy protocol, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinary team and caregiver reviewing an oncology treatment calendar for a dogNamed profile MOPP and LOPP for Canine Lymphoma: Distinct Alkylator-Rich ProtocolsRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · MOPP / LOPP lymphoma protocols · Dogs · After Chemotherapy · During Chemotherapy · New Diagnosis

MOPP and LOPP for Canine Lymphoma: Distinct Alkylator-Rich Protocols

MOPP and LOPP multi-agent chemotherapy is covered as alkylator-rich canine lymphoma protocols, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Awake cat monitored by a veterinary oncology team with a closed infusion systemRepresentative category illustration – not the named product or a real patient.
Chemotherapy · Prescription Drug · CMOP feline lymphoma protocol · Cats · During Chemotherapy · New Diagnosis · Limited / Emerging Evidence

Feline CMOP for Intermediate- to Large-Cell Lymphoma

cyclophosphamide, mitoxantrone, vincristine and prednisolone is covered as multi-agent feline lymphoma chemotherapy protocol, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinary team and caregiver reviewing an oncology treatment calendar for a dogNamed profile Vinblastine and Prednisone or Prednisolone for Canine Mast Cell TumoursRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Vinblastine-glucocorticoid mast-cell-tumour protocols · Dogs · After Surgery · During Chemotherapy · Long-term Management

Vinblastine and Prednisone or Prednisolone for Canine Mast Cell Tumours

vinblastine with prednisone or prednisolone is covered as combination chemotherapy for selected canine mast-cell tumours, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinary team and caregiver reviewing an oncology treatment calendar for a dogNamed profile Carboplatin-Based Adjuvant Chemotherapy for Canine OsteosarcomaRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Carboplatin-based canine osteosarcoma protocols · Dogs · After Surgery · During Chemotherapy · Published Study

Carboplatin-Based Adjuvant Chemotherapy for Canine Osteosarcoma

carboplatin-based adjuvant chemotherapy is covered as platinum chemotherapy after local control of canine appendicular osteosarcoma, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more